Abstract
Bacterial antibiotic resistance remains an ever-increasing worldwide problem, requiring new approaches and enzyme targets. Acinetobacter baumannii is recognised as one of the most significant antibiotic-resistant bacteria, capable of carrying up to 45 different resistance genes, and new drug discovery targets for this organism is an urgent priority. Short-chain dehydrogenase/reductase enzymes are a large protein family with >60,000 members involved in numerous biosynthesis pathways. Here, we determined the structure of an SDR protein from A. baumannii and assessed the putative co-factor comparisons with previously co-crystalised enzymes and cofactors. This study provides a basis for future studies to examine these potential co-factors in vitro.
Publisher
Public Library of Science (PLoS)
Reference45 articles.
1. Past, present, and future of antibacterial economics: increasing bacterial resistance, limited antibiotic pipeline, and societal implications.;KH Luepke;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy.,2017
2. Uncovering the mechanisms of Acinetobacter baumannii virulence;CM Harding;Nature Reviews Microbiology,2018
3. Global assessment of the activity of tigecycline against multidrug-resistant Gram-negative pathogens between 2004 and 2014 as part of the tigecycline evaluation and surveillance trial.;A Giammanco;Msphere,2017
4. A global priority list of the TOp TEn resistant Microorganisms (TOTEM) study at intensive care: a prioritization exercise based on multi-criteria decision analysis.;J Rello;European Journal of Clinical Microbiology & Infectious Diseases.,2019
5. Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii;J Vila;Journal of antimicrobial chemotherapy,2007